Evidence map›Paper›PMID 36613891›Full record

ArticleInternational journal of molecular sciences2022

Evaluation of Alternative Risk Stratification Systems in a Large Series of Solitary Fibrous Tumors with Molecular Findings and Ki-67 Index Data: Do They Improve Risk Assessment?

Isidro Machado, Álvaro Blázquez Bujeda, Francisco Giner, María Gema Nieto Morales, Julia Cruz, Javier Lavernia, Samuel Navarro, Antonio Ferrandez, Amparo Ruiz-Sauri, Antonio Llombart-Bosch

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Isidro MachadoPathology Department, Instituto Valenciano de Oncología, 46009 Valencia, Spain.
Álvaro Blázquez BujedaSchool of Medicine, University of Valencia, 46009 Valencia, Spain.ORCID 0000-0002-2644-8247
Francisco GinerPathology Department, University Hospital "La Fe", 46009 Valencia, Spain.
María Gema Nieto MoralesZoology Department, University of Valencia, 46009 Valencia, Spain.ORCID 0000-0001-5119-4691
Julia CruzPathology Department, Instituto Valenciano de Oncología, 46009 Valencia, Spain.
Javier LaverniaDepartment of Oncology, Instituto Valenciano de Oncología, 46009 Valencia, Spain.
Samuel NavarroPathology Department, University of Valencia, 46009 Valencia, Spain.
Antonio FerrandezPathology Department, University of Valencia, 46009 Valencia, Spain.
Amparo Ruiz-SauriPathology Department, University of Valencia, 46009 Valencia, Spain.
Antonio Llombart-BoschPathology Department, University of Valencia, 46009 Valencia, Spain.
Universitat de València · ESFundación Instituto Valenciano de Oncología · ESHospital Universitari i Politècnic La Fe · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical evolution of solitary fibrous tumors (SFTs) is often uncertain and several risk stratification systems (RSS) have been proposed. The Demicco et al. RSS is the most frequently implemented. In this study we aim to validate two alternative RSS (Sugita et al. and G-Score) using results for the Demicco RSS from a previous study of 97 SFTs. In addition, we aim to determine whether reclassified cases had any distinctive molecular features. As the Sugita et al. system substitutes mitotic count with Ki-67 index we also investigated whether Ki-67 results for tissue microarrays are comparable to those obtained using whole tissue sections. In the present study we detected that many cases classified by Demicco RSS as low-risk were reclassified as intermediate risk using the new system (G-score RSS). Kaplan-Meier survival plots for G-Score RSS showed that the low-risk and intermediate-risk SFTs had a similar evolution that contrasted with the more aggressive high-risk group. Moreover, the similar evolution in both low and intermediate-risk groups occurred despite the G-score system being stricter in classifying low-risk tumors. We observed that Sugita RSS does not provide any better risk stratification in comparison with the Demicco RSS, and testing both RSS in our series produced similar Kaplan-Meier survival data. We found some discordant results when comparing whole sections and the corresponding tissue microarrays samples, finding the hotspot areas easier to locate in whole sections. Forty-one SFTs with initial low-risk assigned by the Demicco RSS were reclassified as intermediate-risk by G-score finding both

Indexed as

Severe Fever with Thrombocytopenia SyndromeSolitary Fibrous TumorsBiomarkers, TumorHumansKi-67 AntigenMutationNeoplasm Recurrence, LocalRisk AssessmentBiomarkers, TumorKi-67 AntigenHTER mutationKi-67 indexoverall survivalrisk stratification systemsolitary fibrous tumorTP53 mutation

Identifiers

PMID36613891
PMCPMC9820154
OpenAlexW4313413695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.